Ibandronate in oncology.
Burckhardt
P
P
Department of Internal Medicine, University Hospital, Lausanne, Switzerland.
D015519:Bone Density / Q000187:drug effects; D001859:Bone Neoplasms / Q000556:secondary; D001862:Bone Resorption / Q000517:prevention & control*; D001943:Breast Neoplasms / Q000150:complications; D002118:Calcium / Q000097:blood; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D000077557:Ibandronic Acid; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D004164:Diphosphonates; D002118:Calcium; D000077557:Ibandronic Acid